Double-Digit Revenue Growth Driven by Strategic Initiatives Across Industrial and Advanced Solutions
Focused on Driving Margin Expansion
MARLBOROUGH, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the third quarter ended September 30, 2026.
| Drei Monate bis zum 30. September, | Neun Monate bis zum 30. September, | |||||||||||||||||||||
| (in Millionen, außer Angaben pro Aktie und Prozentangaben) | 2026 | 2025 | Veränderung | 2026 | 2025 | Veränderung | ||||||||||||||||
| Umsatz | $ | 287.5 | $ | 250.8 | 15 | % | $ | 831.6 | $ | 729.3 | 14 | % | ||||||||||
| Bruttomarge | 40.7 | % | 39.5 | % | 39.6 | % | 38.7 | % | ||||||||||||||
| Betriebliche Erträge | $ | 20.8 | $ | 7.9 | NA | $ | 17.6 | $ | 9.8 | NA | ||||||||||||
| Betriebsmarge | 7.2 | % | 3.1 | % | 2.1 | % | 1.3 | % | ||||||||||||||
| Nettoeinnahmen | $ | 20.3 | $ | 7.5 | 171 | % | $ | 27.1 | $ | 17.8 | 52 | % | ||||||||||
| Ergebnis je verwässerter Aktie | $ | 0.47 | $ | 0.18 | 161 | % | $ | 0.63 | $ | 0.42 | 50 | % | ||||||||||
| Nicht-GAAP-Kennzahlen* | ||||||||||||||||||||||
| Bereinigte Bruttomarge | 41.0 | % | 39.8 | % | 39.9 | % | 39.2 | % | ||||||||||||||
| bereinigtes EBITDA | $ | 51.5 | $ | 37.0 | 39 | % | $ | 135.2 | $ | 101.2 | 34 | % | ||||||||||
| Bereinigtes Ergebnis je verwässerter Aktie | $ | 0.61 | $ | 0.35 | 74 | % | $ | 1.49 | $ | 0.96 | 55 | % | ||||||||||
*Die bereinigte Bruttomarge, das bereinigte EBITDA und das bereinigte Ergebnis je verwässerter Aktie enthalten Nicht-GAAP-Anpassungen. Eine Überleitung von den GAAP-Kennzahlen zu den Nicht-GAAP-Kennzahlen ist in dieser Pressemitteilung enthalten.
NA - nicht aussagekräftig.
Management Comments
“We delivered our fourth consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of our guidance,” said Dr. Mark Gitin, Chief Executive Officer of IPG Photonics. “Our performance reflects the strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets. Strong demand for our differentiated welding and additive manufacturing solutions drove growth in Industrial Solutions while disciplined execution of our key strategic initiatives across defense and semiconductor markets led to strong growth in Advanced Solutions. Additionally, I anticipate that our acquisition of Lumibird Medical, which is expected to close in the fourth quarter, will further strengthen our reach, accelerate growth across medical markets, and increase revenue in Advanced Solutions.”
Finanzielle Kennzahlen
| Drei Monate bis zum 30. September, | Neun Monate bis zum 30. September, | ||||||||||||||||
| 2026 | 2025 | Veränderung | 2026 | 2025 | Veränderung | ||||||||||||
| Umsatz nach Anwendungsbereich | |||||||||||||||||
| Industrielösungen | $ | 239,548 | $ | 214,697 | 12 | % | $ | 704,181 | $ | 607,593 | 16 | % | |||||
| Fortschrittliche Lösungen | 47,952 | 36,095 | 33 | % | 127,396 | 121,713 | 5 | % | |||||||||
| Insgesamt | $ | 287,500 | $ | 250,792 | 15 | % | $ | 831,577 | $ | 729,306 | 14 | % | |||||
Third quarter revenue of $288 million increased 15% year over year, driven by 12% growth in Industrial Solutions and 33% growth in Advanced Solutions. Changes in foreign exchange rates increased revenue by approximately 1%. Industrial Solutions sales, accounting for 83% of total revenue, were driven by strong performance in welding and additive manufacturing applications. Advanced Solutions sales improved, driven by higher sales in semiconductor and defense applications. Emerging growth products accounted for 52% of total revenue, down from 58% in the prior quarter due to product mix. By region, sales increased 14% in Asia and 33% in North America and decreased 1% in Europe on a year-over-year basis.
GAAP gross margin of 40.7% and adjusted gross margin of 41.0% increased year over year, driven by lower product costs and $5.0 million in net tariff refunds recorded in the period, partially offset by lower fixed cost absorption. Net income was $20 million, or $0.47 per diluted share, and adjusted EBITDA was $52 million and adjusted earnings per diluted share (EPS) was $0.61 in the third quarter. During the third quarter, IPG generated $46 million in cash flow from operations and spent $17 million on capital expenditures.
Geschäftssicht und Finanzprognose
“Our third quarter book-to-bill was approximately one as we continued to see improved industrial demand and executed on our strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers. As we move forward, we remain focused on driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio,” concluded Dr. Gitin.
For the fourth quarter of 2026, IPG expects revenue of $265 million to $295 million, adjusted gross margin between 37.0% and 40.0% and adjusted operating expenses of $91 million to $94 million. IPG anticipates delivering adjusted earnings per diluted share in the range of $0.30 to $0.60 and adjusted EBITDA in the range of $33 million to $50 million. The guidance assumes no contribution from the acquisition of Lumibird Medical.
As discussed in more detail in the "Safe Harbor" passage of this news release, actual results may differ from this guidance due to various factors including, but not limited to, trade policy changes and trade restrictions, product demand, order cancellations and delays, competition, tariffs and retaliatory tariffs, currency fluctuations and general economic conditions. The current uncertainty related to the trade environment and tariff policies increases the risks to the outlook that we have provided. This guidance is based upon current market conditions and expectations and is subject to the risks outlined in the Company's reports filed with the SEC and assumes exchange rates relative to the U.S. dollar of euro 0.88, Japanese yen 157 and Chinese yuan 6.74, respectively.
Zusätzliche Finanzinformationen
Additional supplemental financial information is provided in the unaudited Financial Data Workbook and Third Quarter 2026 Earnings Call Presentation available on the investor relations section of the Company's website at investor.ipgphotonics.com.
Erinnerung an die Telefonkonferenz
The Company will hold a conference call today, November 3, 2026 at 10:00 am ET. To access the call, please dial 877-407-6184 in the US or 201-389-0877 internationally. A live webcast of the call will also be available and archived on the investor relations section of the Company's website at investor.ipgphotonics.com.
Kontakt
Eugene Fedotoff
Leitender Direktor, Investor Relations
IPG Photonics Corporation
508-597-4713
efedotoff@ipgphotonics.com
Über IPG Photonics Corporation
Innovation is at the heart of IPG Photonics. As a global leader in laser technology, we apply light to transform the world. From manufacturing to medical and beyond, our breakthrough laser solutions power our customers’ success and expand what's possible. Discover more at www.ipgphotonics.com.
Safe Harbor Statement
Information and statements provided by IPG and its employees, including statements in this press release, that relate to future plans, events or performance are forward-looking statements. These statements involve risks and uncertainties. Any statements in this press release that are not statements of historical fact are forward-looking statements, including those statements related to strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets, the expected timing of the closing of our acquisition of Lumibird Medical and the expectation that the acquisition will increase revenue in Advanced Solutions and strengthen our reach and accelerate growth across medical markets, strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers, driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio, revenue, adjusted gross margin and adjusted operating expenses outlook, adjusted earnings per diluted share and adjusted EBITDA guidance, including the expected impact of tariffs, and the impact of the U.S. dollar on our guidance for the fourth quarter of 2026. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the strength or weakness of business conditions in industries and geographic markets that IPG serves, particularly the effect of downturns in the markets IPG serves; uncertainties and adverse changes in the general economic conditions of markets; inability to manage risks associated with international customers and operations; changes in trade controls and tariff policies; IPG's ability to penetrate new applications for fiber lasers and increase market share; the rate of acceptance and penetration of IPG's products; foreign currency fluctuations; high levels of fixed costs from IPG's vertical integration; the appropriateness of IPG's manufacturing capacity for the level of demand; competitive factors, including declining average selling prices; the effect of acquisitions and investments; inventory write-downs; asset impairment charges; intellectual property infringement claims and litigation; interruption in supply of key components; manufacturing risks; government regulations and trade sanctions; and other risks identified in IPG's SEC filings. Readers are encouraged to refer to the risk factors described in IPG's Annual Report on Form 10-K (filed with the SEC for the fiscal year ended December 31, 2025), IPG's Quarterly Report on Form 10-Q (filed with the SEC for the quarter ended June 30, 2026), and other reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date hereof. IPG undertakes no obligation to update the forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) |
|||||||||||||
| Drei Monate bis zum 30. September, | Neun Monate bis zum 30. September, | ||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||
| (in Tausend, außer Angaben je Aktie) | |||||||||||||
| Nettoumsatzerlöse | $ | 287,500 | $ | 250,792 | $ | 831,577 | $ | 729,306 | |||||
| Umsatzkosten | 170,446 | 151,787 | 502,500 | 446,916 | |||||||||
| Bruttogewinn | 117,054 | 99,005 | 329,077 | 282,390 | |||||||||
| Betriebskosten: | |||||||||||||
| Vertrieb und Marketing | 23,934 | 23,771 | 72,286 | 73,753 | |||||||||
| Forschung und Entwicklung | 31,335 | 30,358 | 95,648 | 88,631 | |||||||||
| Allgemeines und Verwaltung | 37,502 | 35,092 | 110,139 | 102,782 | |||||||||
| Beilegung von Rechtsstreitigkeiten | - | - | 13,334 | - | |||||||||
| Wertminderungsaufwendungen | 231 | - | 17,805 | - | |||||||||
| Restrukturierungskosten | - | 425 | - | 425 | |||||||||
| Wechselkursverlust | 3,275 | 1,504 | 2,293 | 7,013 | |||||||||
| Gesamtbetriebskosten | 96,277 | 91,150 | 311,505 | 272,604 | |||||||||
| Betriebliche Erträge | 20,777 | 7,855 | 17,572 | 9,786 | |||||||||
| Sonstige Erträge, netto: | |||||||||||||
| Zinserträge, netto | 7,688 | 7,283 | 21,720 | 22,728 | |||||||||
| Other (expense) income, net | (50 | ) | 516 | 2,683 | 2,026 | ||||||||
| Sonstige Erträge gesamt | 7,638 | 7,799 | 24,403 | 24,754 | |||||||||
| Ergebnis vor Ertragsteuern | 28,415 | 15,654 | 41,975 | 34,540 | |||||||||
| Rückstellung für Ertragsteuern | 8,142 | 8,191 | 14,876 | 16,714 | |||||||||
| Nettoeinnahmen | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | |||||
| Gewinn je Stammaktie: | |||||||||||||
| Grundlage | $ | 0.48 | $ | 0.18 | $ | 0.64 | $ | 0.42 | |||||
| Verwässert | $ | 0.47 | $ | 0.18 | $ | 0.63 | $ | 0.42 | |||||
| Gewichteter Durchschnitt der im Umlauf befindlichen Stammaktien: | |||||||||||||
| Grundlage | 42,531 | 42,199 | 42,416 | 42,427 | |||||||||
| Verwässert | 42,840 | 42,556 | 42,904 | 42,659 | |||||||||
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) |
||||||||
| 30. September, | 31. Dezember, | |||||||
| 2026 | 2025 | |||||||
| (In thousands, except share data) | ||||||||
| VERMÖGEN | ||||||||
| Umlaufvermögen: | ||||||||
| Zahlungsmittel und Zahlungsmitteläquivalente | $ | 710,688 | $ | 403,790 | ||||
| Kurzfristige Investitionen | 215,304 | 435,538 | ||||||
| Forderungen aus Lieferungen und Leistungen, netto | 191,150 | 181,734 | ||||||
| Lagerbestände | 337,890 | 313,416 | ||||||
| Vorausbezahlte Ertragssteuern | 33,145 | 43,196 | ||||||
| Rechnungsabgrenzungsposten und sonstiges Umlaufvermögen | 54,460 | 45,766 | ||||||
| Umlaufvermögen insgesamt | 1,542,637 | 1,423,440 | ||||||
| Langfristige Investitionen | - | 76,533 | ||||||
| Latente Ertragssteuern, netto | 122,235 | 123,889 | ||||||
| Kulanz | 70,281 | 71,735 | ||||||
| Immaterielle Vermögenswerte, netto | 42,777 | 49,933 | ||||||
| Sachanlagen, netto | 648,326 | 637,516 | ||||||
| Sonstige Aktiva | 45,787 | 41,234 | ||||||
| Gesamtvermögen | $ | 2,472,043 | $ | 2,424,280 | ||||
| VERBINDLICHKEITEN UND EIGENKAPITAL | ||||||||
| Kurzfristige Verbindlichkeiten: | ||||||||
| Verbindlichkeiten aus Lieferungen und Leistungen | $ | 48,782 | $ | 39,288 | ||||
| Passive Rechnungsabgrenzungsposten und sonstige kurzfristige Verbindlichkeiten | 204,874 | 184,849 | ||||||
| Zu zahlende Ertragssteuern | 3,858 | 9,900 | ||||||
| Kurzfristige Verbindlichkeiten insgesamt | 257,514 | 234,037 | ||||||
| Sonstige langfristige Verbindlichkeiten und latente Ertragsteuern | 59,581 | 62,113 | ||||||
| Verbindlichkeiten insgesamt | 317,095 | 296,150 | ||||||
| Verpflichtungen und Eventualitäten | ||||||||
| Eigenkapital: | ||||||||
| Common stock, $0.0001 par value, 175,000,000 shares authorized; 57,380,668 and 42,508,140 shares issued and outstanding, respectively, at September 30, 2026; 56,964,939 and 42,127,067 shares issued and outstanding, respectively, at December 31, 2025. |
6 | 6 | ||||||
| Treasury stock, at cost, 14,872,528 and 14,837,872 shares held at September 30, 2026 and December 31, 2025, respectively. |
(1,558,277 | ) | (1,555,629 | ) | ||||
| Rücklage für eingezahltes Kapital | 1,097,673 | 1,077,172 | ||||||
| Einbehaltene Gewinne | 2,672,063 | 2,644,964 | ||||||
| Kumulierter sonstiger Gesamtverlust | (56,517 | ) | (38,383 | ) | ||||
| Gesamtkapital | 2,154,948 | 2,128,130 | ||||||
| Gesamtverbindlichkeiten und Eigenkapital | $ | 2,472,043 | $ | 2,424,280 | ||||
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) |
||||||||
| Neun Monate bis zum 30. September, | ||||||||
| 2026 | 2025 | |||||||
| (in Tausend) | ||||||||
| Cashflow aus betrieblicher Tätigkeit: | ||||||||
| Nettoeinnahmen | $ | 27,099 | $ | 17,826 | ||||
| Anpassungen zur Überleitung des Jahresüberschusses zum Nettomittelzufluss aus betrieblicher Tätigkeit: | ||||||||
| Abschreibung und Amortisation | 47,377 | 46,799 | ||||||
| Wertminderungsaufwendungen | 17,805 | - | ||||||
| Rückstellungen für das Inventar, Gewährleistungen und uneinbringliche Forderungen | 33,594 | 31,766 | ||||||
| Andere | 25,081 | 21,119 | ||||||
| Changes in assets and liabilities that provided (used) cash: | ||||||||
| Forderungen und Verbindlichkeiten aus Lieferungen und Leistungen | 1,535 | 18,787 | ||||||
| Lagerbestände | (60,189 | ) | (52,005 | ) | ||||
| Andere | (13,771 | ) | (37,757 | ) | ||||
| Nettomittelzufluss aus der betrieblicher Tätigkeit | 78,531 | 46,535 | ||||||
| Cashflow aus Investitionstätigkeit: | ||||||||
| Käufe von und Anzahlungen auf Sachanlagen | (54,437 | ) | (60,907 | ) | ||||
| Erlöse aus dem Verkauf von Sachanlagen | 2,204 | 605 | ||||||
| Erwerb von Kapitalanlagen | (360,732 | ) | (866,402 | ) | ||||
| Purchases of equity investment | (8,000 | ) | - | |||||
| Erlöse aus fälligen Kapitalanlagen | 663,124 | 633,731 | ||||||
| Vom Käufer erhaltene Anzahlung für zur Veräußerung gehaltene Vermögenswerte | 2,000 | - | ||||||
| Andere | 111 | 69 | ||||||
| Nettomittelzufluss/(-abfluss) aus Investitionstätigkeit | 244,270 | (292,904 | ) | |||||
| Cashflow aus der Finanzierungstätigkeit: | ||||||||
| Payments for taxes related to net share settlement of equity awards less proceeds from issuance of common stock under employee stock option and purchase plans |
(11,053 | ) | (4,316 | ) | ||||
| Erwerb eigener Aktien abzüglich Verbrauchssteuer, zu Anschaffungskosten | (2,648 | ) | (46,603 | ) | ||||
| Nettomittelabfluss aus der Finanzierungstätigkeit | (13,701 | ) | (50,919 | ) | ||||
| Auswirkungen von Wechselkursänderungen auf Zahlungsmittel, Zahlungsmitteläquivalente und zur Veräußerung gehaltene Zahlungsmittel | (1,727 | ) | 23,274 | |||||
| Net increase (decrease) in cash, cash equivalents and cash held for sale | 307,373 | (274,014 | ) | |||||
| Zahlungsmittel und Zahlungsmitteläquivalente - Beginn des Zeitraums | 403,790 | 620,040 | ||||||
| Zahlungsmittel, Zahlungsmitteläquivalente und zur Veräußerung gehaltene Zahlungsmittel — Stand zum Ende der Berichtsperiode | $ | 711,163 | $ | 346,026 | ||||
| Zusätzliche Angaben zu den Cashflow-Informationen: | ||||||||
| Auszahlungen für Zinsen | $ | 54 | $ | 136 | ||||
| Barzahlungen für Einkommensteuern, abzüglich Rückerstattungen | $ | 9,273 | $ | 44,258 | ||||
| IPG PHOTONICS CORPORATION ERGÄNZENDE AUFSTELLUNG VON NICHT-GAAP-KENNZAHLEN (UNGEPRÜFT) |
||||||||
Verwendung von nicht GAAP-bereinigten Finanzinformationen
We refer to certain financial measures that are not recognized under United States generally accepted accounting principles (“GAAP”) and are provided as supplemental information to enhance understanding of the Company’s financial performance. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measure presented by the Company. The following information provides the definition of adjusted gross profit, adjusted gross margin, adjusted operating expense and resultant adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted net earnings per share (EPS), and adjusted tax rate as presented, which are financial measures that are not calculated or presented in accordance with GAAP, and reconciliation to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided adjusted gross profit, adjusted gross margin, adjusted operating expense and resultant adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted EPS, and an adjusted tax rate as supplemental information and in addition to the financial measures presented by the Company that are calculated and presented in accordance with GAAP.
We define adjusted gross profit as reported gross profit, adjusted for non-recurring, infrequent, or unusual charges, including acquisition and integration charges and amortization of acquisition-related intangibles.
Wir definieren die bereinigte Bruttomarge als bereinigten Bruttogewinn geteilt durch den Gesamtumsatz.
We define adjusted operating expense and resultant adjusted operating income as reported operating expenses and resultant operating income, adjusted for non-recurring, infrequent, or unusual charges, including impairment charges, settlement and fees of litigation matters, restructuring charges, acquisition and integration charges, amortization of acquisition-related intangibles, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.
Wir definieren das EBITDA als Jahresüberschuss zuzüglich Zinsaufwendungen (Zinserträge), Ertragsteueraufwendungen, Abschreibungen und Amortisationsaufwendungen.
We define adjusted EBITDA as EBITDA adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including stock-based compensation, restructuring charges, impairment charges, settlement and fees of litigation matters, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.
We define adjusted net income as reported net income, adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including impairment charges, settlement and fees of litigation matters, restructuring charges, amortization of acquisition-related intangibles, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture, certain discrete tax items and non-GAAP income tax reconciling adjustments.
Wir definieren das bereinigte Ergebnis je Aktie als bereinigten Jahresüberschuss geteilt durch die gewichtete durchschnittliche Anzahl der im Umlauf befindlichen verwässerten Aktien.
Wir definieren den bereinigten Steuersatz als den GAAP-Steuersatz, bereinigt um einmalige Steuerposten und die Nettoauswirkungen von Nicht-GAAP-Anpassungen.
Die Unternehmensleitung ist der Ansicht, dass diese nicht GAAP-konformen Finanzkennzahlen zusätzliche Möglichkeiten zur Bewertung der operativen Leistung im Zeitvergleich bieten. Insbesondere bieten diese nicht GAAP-konformen Finanzkennzahlen der Unternehmensleitung zusätzliche Möglichkeiten, die operativen Ergebnisse und Trends unseres laufenden Geschäfts zu verstehen und zu bewerten, indem bestimmte nicht zahlungswirksame Aufwendungen und andere Posten herausgerechnet werden, die nach Ansicht der Unternehmensleitung andernfalls Vergleiche unseres laufenden Geschäfts mit früheren Perioden erschweren, Trends im laufenden Geschäft verschleiern oder die Fähigkeit der Unternehmensleitung beeinträchtigen könnten, aussagekräftige Prognosen zu erstellen.
In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors. However, these non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies. Management may, however, utilize other measures to illustrate performance in the future. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of our non-GAAP financial measures to their most directly comparable GAAP measures has been provided below. These non-GAAP measures exclude (i) amortization of acquisition-related intangibles, (ii) restructuring charges, (iii) acquisition and integration costs, (iv) impairment charges, (v) foreign exchange gains/losses, (vi) interest income, (vii) benefit (provision) from income taxes, (viii) depreciation, (ix) amortization, (x) stock-based compensation, (xi) gain/loss on disposal of assets/divestiture, (xii) settlement and fees of litigation matters, (xiii) certain discrete tax items, and (xiv) non-GAAP income tax reconciling adjustments.
Wir haben keine quantitative Überleitung des zukunftsgerichteten, nicht nach GAAP bereinigten Gewinns je verwässerter Aktie und des bereinigten EBITDA zu den am ehesten vergleichbaren GAAP-Finanzkennzahlen vorgenommen, da wir den endgültigen Zeitpunkt oder die Höhe bestimmter wesentlicher Posten nicht mit hinreichender Sicherheit und ohne unverhältnismäßigen Aufwand abschätzen können. Dies ist auf die inhärente Schwierigkeit zurückzuführen, den Zeitpunkt und/oder die Höhe verschiedener Posten zu prognostizieren, die sich auf den bereinigten Gewinn je verwässerter Aktie und das bereinigte EBITDA auswirken würden. Dazu gehören Posten, die noch nicht eingetreten sind, außerhalb der Kontrolle des Unternehmens liegen, nicht vernünftig vorhergesagt werden können und/oder für die es keine wesentliche Anpassung oder Differenz geben würde. Aus denselben Gründen ist das Unternehmen nicht in der Lage, die wahrscheinliche Bedeutung der nicht verfügbaren Informationen zu beurteilen.
Our non-GAAP tax provision for the fiscal third quarter of 2026 is 23%. The difference between our GAAP income tax provision and our non-GAAP income tax provision is presented as non-GAAP income tax reconciling adjustments.
| IPG PHOTONICS CORPORATION SUPPLEMENTAL SCHEDULE OF NON-GAAP MEASURES (UNAUDITED) |
||||||||||||||||
| Überleitung vom Bruttogewinn zum bereinigten Bruttogewinn und zur bereinigten Bruttomarge | ||||||||||||||||
| Drei Monate bis zum 30. September, | Neun Monate bis zum 30. September, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| (in Tausend, außer Prozentangaben) | ||||||||||||||||
| Bruttogewinn | $ | 117,054 | $ | 99,005 | $ | 329,077 | $ | 282,390 | ||||||||
| Bruttomarge | 40.7 | % | 39.5 | % | 39.6 | % | 38.7 | % | ||||||||
| Abschreibung von immateriellen Vermögenswerten im Zusammenhang mit Unternehmenserwerben | 720 | 851 | 2,360 | 2,928 | ||||||||||||
| Kosten für Akquisitionen und Integrationen | - | - | - | 482 | ||||||||||||
| Bereinigter Bruttogewinn | $ | 117,774 | $ | 99,856 | $ | 331,437 | $ | 285,800 | ||||||||
| Bereinigte Bruttomarge | 41.0 | % | 39.8 | % | 39.9 | % | 39.2 | % | ||||||||
Reconciliation of Operating Expenses to Adjusted Operating Expenses
| Drei Monate bis zum 30. September, | Neun Monate bis zum 30. September, | |||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||
| (in Tausend) | ||||||||||||
| Operating expenses | $ | 96,277 | $ | 91,150 | $ | 311,505 | $ | 272,604 | ||||
| Less: | ||||||||||||
| Abschreibung von immateriellen Vermögenswerten im Zusammenhang mit Unternehmenserwerben | 1,231 | 1,551 | 3,701 | 4,570 | ||||||||
| Kosten für Akquisitionen und Integrationen | 151 | 246 | 987 | 1,823 | ||||||||
| Wertminderungsaufwendungen | 231 | - | 17,805 | - | ||||||||
| Restrukturierungskosten | 149 | 425 | 500 | 425 | ||||||||
| Vergleich und Kosten in Rechtsstreitigkeiten | - | - | 14,435 | - | ||||||||
| Wechselkursverlust | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||
| Adjusted operating expenses | $ | 91,240 | $ | 87,424 | $ | 271,784 | $ | 258,773 | ||||
Reconciliation of Operating Income to Adjusted Operating Income
| Drei Monate bis zum 30. September, | Neun Monate bis zum 30. September, | |||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||
| (in Tausend) | ||||||||||||
| Betriebliche Erträge | $ | 20,777 | $ | 7,855 | $ | 17,572 | $ | 9,786 | ||||
| Abschreibung von immateriellen Vermögenswerten im Zusammenhang mit Unternehmenserwerben | 1,951 | 2,402 | 6,061 | 7,498 | ||||||||
| Kosten für Akquisitionen und Integrationen | 151 | 246 | 987 | 2,305 | ||||||||
| Wertminderungsaufwendungen | 231 | - | 17,805 | - | ||||||||
| Restrukturierungskosten | 149 | 425 | 500 | 425 | ||||||||
| Vergleich und Kosten in Rechtsstreitigkeiten | - | - | 14,435 | - | ||||||||
| Wechselkursverlust | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||
| Bereinigtes Betriebsergebnis | $ | 26,534 | $ | 12,432 | $ | 59,653 | $ | 27,027 | ||||
Überleitung vom Jahresüberschuss zum bereinigten EBITDA
| Drei Monate bis zum 30. September, | Neun Monate bis zum 30. September, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| (in Tausend) | ||||||||||||||||
| Nettoeinnahmen | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | ||||||||
| Zinserträge, netto | (7,688 | ) | (7,283 | ) | (21,720 | ) | (22,728 | ) | ||||||||
| Rückstellung für Ertragsteuern | 8,142 | 8,191 | 14,876 | 16,714 | ||||||||||||
| Abschreibung | 12,986 | 12,392 | 38,447 | 36,120 | ||||||||||||
| Abschreibung | 2,976 | 3,240 | 8,930 | 10,679 | ||||||||||||
| EBITDA | $ | 36,689 | $ | 24,003 | $ | 67,632 | $ | 58,611 | ||||||||
| Wertminderungsaufwendungen | 231 | - | 17,805 | - | ||||||||||||
| Aktienbasierte Vergütung | 11,022 | 10,780 | 31,597 | 32,834 | ||||||||||||
| Restrukturierungskosten | 149 | 425 | 500 | 425 | ||||||||||||
| Kosten für Akquisitionen und Integrationen | 151 | 246 | 987 | 2,305 | ||||||||||||
| Vergleich und Kosten in Rechtsstreitigkeiten | - | - | 14,435 | - | ||||||||||||
| Wechselkursverlust | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||||||
| bereinigtes EBITDA | $ | 51,517 | $ | 36,958 | $ | 135,249 | $ | 101,188 | ||||||||
Überleitung vom GAAP- zum Non-GAAP-Nettoergebnis sowie vom GAAP- zum Non-GAAP-Nettoergebnis je Aktie (verwässert)
| Drei Monate bis zum 30. September, | Neun Monate bis zum 30. September, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| (in Tausend, außer Angaben pro Aktie) | ||||||||||||||||
| Nettoeinnahmen | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | ||||||||
| Wertminderungsaufwendungen | 231 | - | 17,805 | - | ||||||||||||
| Abschreibung von immateriellen Vermögenswerten im Zusammenhang mit Unternehmenserwerben | 1,951 | 2,402 | 6,061 | 7,498 | ||||||||||||
| Restrukturierungskosten | 149 | 425 | 500 | 425 | ||||||||||||
| Kosten für Akquisitionen und Integrationen | 151 | 246 | 987 | 2,305 | ||||||||||||
| Vergleich und Kosten in Rechtsstreitigkeiten | - | - | 14,435 | - | ||||||||||||
| Wechselkursverlust | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||||||
| Bestimmte einzelne Steuerposten | 949 | 3,414 | 84 | 8,303 | ||||||||||||
| Steuerliche Auswirkungen von Nicht-GAAP-Anpassungen | (711 | ) | (613 | ) | (5,337 | ) | (2,471 | ) | ||||||||
| Bereinigter Jahresüberschuss | $ | 26,268 | $ | 14,841 | $ | 63,927 | $ | 40,899 | ||||||||
| Bereinigter Nettogewinn je verwässerter Aktie | $ | 0.61 | $ | 0.35 | $ | 1.49 | $ | 0.96 | ||||||||
| Gewichteter Durchschnitt der im Umlauf befindlichen verwässerten Aktien | 42,840 | 42,556 | 42,904 | 42,659 | ||||||||||||
Überleitung des effektiven Steuersatzes nach GAAP zum effektiven Steuersatz nach Non-GAAP
| Drei Monate bis zum 30. September, | Neun Monate bis zum 30. September, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Steuersatz | 29 | % | 52 | % | 35 | % | 48 | % | ||||||||
| Einzelne Steuerposten | (3 | ) | % | (22 | ) | % | - | % | (24 | ) | % | |||||
| Nettoauswirkung der Nicht-GAAP-Anpassungen | (3 | ) | % | (3 | ) | % | (11 | ) | % | (3 | ) | % | ||||
| Bereinigter Steuersatz | 23 | % | 27 | % | 24 | % | 21 | % | ||||||||
